Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oesch

Showing results (561-570 of 713) with videos related to

Pageof 72
Sort By:
The EMBO Journal|March 15, 1996
Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapieM Fischer, T Rülicke, A Raeber, et al.
Melanoma Research|December 1, 1996
Cytolytic T cell reactivity against melanoma-associated differentiation antigens in peripheral blood of melanoma patients and healthy individualsE Jäger, M Ringhoffer, M Arand, et al.
Carcinogenesis|December 17, 1998
Detoxification of optically active bay- and fjord-region polycyclic aromatic hydrocarbon dihydrodiol epoxides by human glutathione transferase P1-1 expressed in Chinese hamster V79 cellsA Seidel, T Friedberg, B Löllmann, et al.
Neurobiology of Disease|May 17, 2005
Aggravation of ischemic brain injury by prion protein deficiency: role of ERK-1/-2 and STAT-1Annett Spudich, Rico Frigg, Ertugrul Kilic, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 1, 1992
Applications of stable V79-derived cell lines expressing rat cytochromes P4501A1, 1A2, and 2B1J Doehmer, C Wölfel, S Dogra, et al.
Carcinogenesis|June 1, 1991
The metabolic activation of dibenz[a,h]anthracene in mouse skin examined by 32P-postlabelling: minor contribution of the 3,4-diol 1,2-oxides to DNA bindingS Lecoq, M N She, A Hewer, et al.
Scientific Reports|November 21, 2020
Two-year outcomes of intravitreal aflibercept in a Swiss routine treat and extend regimen for patients with neovascular age-related macular degenerationAndreas Ebneter, Stephan Michels, Christian Pruente, et al.
BMC Musculoskeletal Disorders|October 27, 2015
Comparison of patients in three different rehabilitation settings after knee or hip arthroplasty: a natural observational, prospective studyT Benz, F Angst, P Oesch, et al.
Cancer Letters|July 4, 1998
Resistance factors in colon cancer tissue and the adjacent normal colon tissue: glutathione S-transferases alpha and pi, glutathione and aldehyde dehydrogenaseJ G Hengstler, T Böttger, B Tanner, et al.
Cancer Research|September 1, 1986
Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolitesH Glatt, A Seidel, W Bochnitschek, et al.
Pageof 72

Showing results (561-570 of 713) with videos related to

Sort By:
Pageof 72
The EMBO Journal|March 15, 1996
Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapieM Fischer, T Rülicke, A Raeber, et al.
Melanoma Research|December 1, 1996
Cytolytic T cell reactivity against melanoma-associated differentiation antigens in peripheral blood of melanoma patients and healthy individualsE Jäger, M Ringhoffer, M Arand, et al.
Carcinogenesis|December 17, 1998
Detoxification of optically active bay- and fjord-region polycyclic aromatic hydrocarbon dihydrodiol epoxides by human glutathione transferase P1-1 expressed in Chinese hamster V79 cellsA Seidel, T Friedberg, B Löllmann, et al.
Neurobiology of Disease|May 17, 2005
Aggravation of ischemic brain injury by prion protein deficiency: role of ERK-1/-2 and STAT-1Annett Spudich, Rico Frigg, Ertugrul Kilic, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 1, 1992
Applications of stable V79-derived cell lines expressing rat cytochromes P4501A1, 1A2, and 2B1J Doehmer, C Wölfel, S Dogra, et al.
Carcinogenesis|June 1, 1991
The metabolic activation of dibenz[a,h]anthracene in mouse skin examined by 32P-postlabelling: minor contribution of the 3,4-diol 1,2-oxides to DNA bindingS Lecoq, M N She, A Hewer, et al.
Scientific Reports|November 21, 2020
Two-year outcomes of intravitreal aflibercept in a Swiss routine treat and extend regimen for patients with neovascular age-related macular degenerationAndreas Ebneter, Stephan Michels, Christian Pruente, et al.
BMC Musculoskeletal Disorders|October 27, 2015
Comparison of patients in three different rehabilitation settings after knee or hip arthroplasty: a natural observational, prospective studyT Benz, F Angst, P Oesch, et al.
Cancer Letters|July 4, 1998
Resistance factors in colon cancer tissue and the adjacent normal colon tissue: glutathione S-transferases alpha and pi, glutathione and aldehyde dehydrogenaseJ G Hengstler, T Böttger, B Tanner, et al.
Cancer Research|September 1, 1986
Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolitesH Glatt, A Seidel, W Bochnitschek, et al.
Pageof 72